Nahar Industrial Enterprises DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.80×0.78×0.79×0.85×0.78×
3.89×6.44×0.98×1.06×1.05×
1.7%0.7%1.6%0.7%5.5%
0.76×0.76×0.89×0.98×1.11×
1.82×1.82×1.81×1.71×1.42×
7.5%5.0%1.9%1.1%7.0%
5.1%5.1%1.9%1.0%8.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

NAHARINDUS₹121.15

Nahar Industrial Enterprises Limited

· Textiles
₹ CrorePeersDCMSILABCOTSDONEARNDLSARLAPOLYMANOMAYBANSWRASBORANAMcap ₹523 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.780.850.790.780.80
Interest Burden (Pretax/EBIT) ×1.051.060.986.443.89
EBIT Margin %5.450.731.570.731.74
Asset Turnover ×1.110.980.890.760.76
Financial Leverage (Assets/Equity) ×1.421.711.811.821.82
ROE (5-step product, year-end total equity) %7.031.111.955.057.48
ROE (owners' profit / average owners' equity) %8.541.011.895.055.05
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.